Archive ready

医薬品医療機器等法に基づく新型コロナウイルス感染症に係る治療薬の承認について｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_18199.html

April 9, 2026 at 03:02 AM JST•The archive page, viewer, and downloads use this saved version.

April 9, 2026 at 03:02 AM JST·www.mhlw.go.jp

Bundle the HTML, screenshot, summaries, and metadata into one ZIP file. Pro saves automatically start preparing the external RFC 3161 timestamp, and only unfinished records need one more preparation step before download.

Saved page

医薬品医療機器等法に基づく新型コロナウイルス感染症に係る治療薬の承認について｜厚生労働省

Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.

Original URLhttps://www.mhlw.go.jp/stf/newpage_18199.html

StartedApril 9, 2026 at 03:02 AM JST

This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.

The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.

About this pageAI generated

This page is a press release from Japan's Ministry of Health, Labour and Welfare dated April 23, 2021, announcing the approval of Olumiant tablets as a COVID-19 treatment. The active ingredient is baricitinib, a JAK inhibitor. It is approved for pneumonia patients requiring oxygen therapy, administered orally at 4mg once daily in combination with remdesivir. The application was filed by Eli Lilly Japan K.K. on December 25, 2020.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.